Allarity Therapeutics (ALLR) Cash from Operations (2020 - 2026)
Allarity Therapeutics' (ALLR) quarterly Cash from Operations came in at 4500000.0 in Q1 2026, down 67.54% YoY from 13861238.53 in Q1 2025, and down 39.75% on a QoQ basis from 3220000.0 in Q4 2025.
Allarity Therapeutics (ALLR) Cash from Operations (2020 - 2026) Analysis & Trends
Allarity Therapeutics (ALLR) has 7 years of Cash from Operations data on file, last reported at 4500000.0 in Q1 2026.
- Quarterly Cash from Operations fell 67.54% year-over-year to 4500000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 16634000.0 (up 10.76% YoY) and the FY2025 annual result came in at 14820000.0, up 14.59% from the prior year.
- Cash from Operations slipped to 4500000.0 in Q1 2026, from 3220000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1399000.0 in Q1 2024 to a low of 7304000.0 in Q2 2024.
- A 5-year average of 3896117.65 and a median of 3400000.0 in 2025 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 56.29% in 2024, down 192.63% in 2024.
- Tracing ALLR's Cash from Operations over 5 years: stood at 2446000.0 in 2022, then soared by 31.64% to 1672000.0 in 2023, then slumped by 91.75% to 3206000.0 in 2024, then retreated by 0.44% to 3220000.0 in 2025, then tumbled by 39.75% to 4500000.0 in 2026.
- The last three Cash from Operations figures came in at 4500000.0 (Q1 2026), 3220000.0 (Q4 2025), and 3400000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - | -2.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.50 Mn |
| Mar 31, 2026 | -4.50 Mn |
| Dec 31, 2025 | -3.22 Mn |
| Dec 31, 2025 | -3.22 Mn |
| Sep 30, 2025 | -3.40 Mn |
| Sep 30, 2025 | -3.40 Mn |
| Jun 30, 2025 | -5.51 Mn |
| Jun 30, 2025 | -5.51 Mn |
| Mar 31, 2025 | -2.69 Mn |
| Mar 31, 2025 | -2.69 Mn |
| Dec 31, 2024 | -3.21 Mn |
| Dec 31, 2024 | -3.21 Mn |
| Sep 30, 2024 | -5.44 Mn |
| Sep 30, 2024 | -5.44 Mn |
| Jun 30, 2024 | -7.30 Mn |
| Jun 30, 2024 | -7.30 Mn |
| Mar 31, 2024 | -1.40 Mn |
| Mar 31, 2024 | -1.40 Mn |
| Dec 31, 2023 | -1.67 Mn |
| Dec 31, 2023 | -1.67 Mn |